learn Rapamycin
mTOR regulator and immunosuppressant used more recently for anti-aging and hair regrowth
Search
forLearn
5 / 801 resultslearn Osteopontin
signaling protein that, when suppressed, may grow hair by reducing inflammation and stem cell loss
learn Overview
learn Thymosin Beta 4
learn medium chain triglycerides
Research
5 / 1000+ results
research High-performance liquid chromatographic determination of the enantiomers of the benzoquinolinone LY 191704, a human type 1 5α-reductase inhibitor, in plasma
Researchers developed a method to measure different forms of a drug that could help treat prostate issues and hair loss, and found how these forms behave in animals.
research A Comprehensive Review on Metabolic Syndrome
Managing metabolic syndrome needs both lifestyle changes and medical treatments.
research Testosterone replacement in 49,XXXXY syndrome: andrological, metabolic and neurological aspects
Testosterone therapy improved physical and social health in a male with 49,XXXXY syndrome.
research Changes of metabolic profile in men treated for androgenetic alopecia with 1 mg finasteride
Taking 1mg of finasteride daily can mildly improve metabolic health and glucose regulation in men with male pattern baldness.
research Follow-up of Nutritional and Metabolic Problems After Bariatric Surgery
Patients need long-term care after bariatric surgery to manage potential nutritional and metabolic issues.
Community Join
5 / 1000+ resultscommunity Study: Dutasteride Mesotherapy Accelerates Hair Loss in Female Patients with Metabolic Syndrome
Dutasteride mesotherapy in women with metabolic syndrome accelerated hair loss after initial regrowth, while women without metabolic syndrome saw continuous regrowth. The user with mild insulin resistance is hesitant to try topical dutasteride and seeks experiences from others with insulin resistance.
community Debunking the "Adverse metabolic consequences of dutasteride"
Dutasteride is more effective than finasteride, has neuroprotective benefits, and may prevent acne. Despite initial concerns about metabolic effects, further research suggests it is safe for most users, especially if not hypogonadal.
community Pp405 phase 2a clinical results
PP405 shows initial promise for treating androgenetic alopecia, with safety confirmed in early trials, but skepticism remains due to limited data. Further trials are needed to determine its true efficacy and potential market impact.
community Update to fin 0.25 mg, 4x/week
User reported initial hair regrowth with 0.25 mg finasteride taken four times a week, experiencing a second shedding phase, and no side effects. They also mentioned using RU58841 without success and plan to stop after a year.
community Day 1 vs 1 month vs 4 months vs 6 months vs 1 year vs 1 year 3 months (My story)
A 23-year-old experienced hair regrowth using 1mg finasteride and 5mg oral minoxidil after initial shedding, but noticed hair loss after stopping minoxidil and starting vaping. They resumed oral minoxidil and finasteride, attributing hair loss to nicotine and stopping minoxidil, and are considering additional treatments like dutasteride.